Pharmacists can have significant responsibilities within neurology and psychiatric care teams involved in ensuring patients with complex neurological conditions understand the intricate dosing, administration requirements, and adverse effect profiles of specialized regimens. The 2026 Neurology and Psychiatric Pharmacy Day of Education provides pharmacists with evidence-based updates on the use of targeted immunologic therapies, including complement inhibitors, FcRn inhibitors, and B-cell–directed agents. Join PTCE for two expert-led discussions designed to support understanding of disease pathophysiology, managing challenging adverse effects, and driving patient adherence in chronic and relapsing neurological conditions. See the full agenda for specific session details and topics.





